Submitted for Publication: April 4, 2012; final revision received June 20, 2012; accepted July 25, 2012.
Published Online: March 13, 2013. doi:10.1001/jamapsychiatry.2013.87
Author Contributions: All authors had full access to all the data in the study; Drs Wisner and Wisniewski take responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of Interest Disclosures: Dr Wisner participated in an advisory board for Eli Lilly Company and received donated estradiol and placebo transdermal patches from Novartis for a National Institute of Mental Health–funded randomized trial, activities that do not involve the work described in this article. Dr Wisniewski has received compensation for consultation to Bristol-Myers Squibb Company (2007-2008), Organon (2007), Case Western Reserve University (2007), Singapore Clinical Research Institute (2009), Dey Pharmaceuticals (2010), and Venebio (2010) and received payment for his board membership for Cyberonic, Inc (2005-2009).
Funding Support: This study was supported by grant R01 MH 071825 for Identification and Therapy of Postpartum Depression (Dr Wisner, principal investigator).
Previous Presentation: Preliminary data for this study were presented at the Marce Society meeting; October 4, 2012; Paris, France.
Additional Contributions: Sarah Scholle, PhD, performed pioneering work in this area while she was at the University of Pittsburgh. The staff at Magee-Womens Hospital, including Terri Redpath, RN, Veta Farmer, MSW, Leah Kelly, MSN, Darla Lane, RN, Rosanne Salt, RN, Jeanne Kingston, RN, Jessica Lott, RN, Lisa Karow, RN, Lisa Stein, RN, and Karen Pennington, RN, offered screening to new mothers. Tracey Capotosto, MBA, arranged the references for this manuscript.